跳至主要内容
临床试验/NCT07640321
NCT07640321已完成不适用

Assessment and Comparison on 3 Groups of 25 Human Beings of the Effect on the Cutaneous State, the Dermis Echogenicity, the Moisturizing Effect, the Depigmenting Effect, the Effect on the Biomechanical Properties and the Effect on Wrinkles, Color and Homogeneity and Pigmentary Spots of Cosmetic Product N°1 vs Cosmetic Product N°2 vs Placebo After Oral Intake in Conditions of Normal Use During 28, 56 and 84 Days: Self-assessment of the Cosmetic Qualities and Efficacy

Wuhan CASOV Green Biotech Co., Ltd1 个研究点 分布在 1 个国家目标入组 83 人开始时间: 2023年9月25日最近更新:

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
83
试验地点
1

研究概览

简要总结

Evaluate and compare the effects on female facial skin of oral placebo (Product A), N-acetylneuraminic acid (Product B), and ACAI-PLUS (Product C) after 28, 56, and 84 days under normal usage conditions.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Cross Sectional

入排标准

年龄范围
40 Years 至 65 Years(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Skin type origin: Asian in China
  • Age: from 40 to 65 years old
  • Gender: female
  • Specific criteria:
  • All skin type on the face Dry, dry combination, normal
  • presenting with a lack of elasticity to the face, inclusion grade
  • ≤ 6 according 10 points scale
  • presenting with a lack of density to the face, inclusion grade ≤ 6 according 10 points scale
  • presenting with wrinkles on crow's feet area, grade ≥ 2 according to Skin ageing atlas Vol.2 (p.41)
  • presenting with pigmentary spots with at least one with diameter ≥ 3mm
  • Usual or occasional user of food supplements
  • Able to give her informed consent

排除标准

  • The non-inclusion general criteria were the following ones:
  • allergies or reactivity to cosmetic products,
  • for the subjects undergoing hormonal treatment; change of treatment within 3 months preceding the inclusion visit,
  • expectation of change in the current hormonal treatment during the study,
  • anti-allergic, antibiotic, anti-inflammatory, dermatological treatment or corticosteroid therapy within 2 weeks before the inclusion visit,
  • having a chronic pathology,
  • performing or prevision to perform another test during the study or during the exclusion period,
  • employee of the COSderma laboratory,
  • pregnant or breast-feeding woman,
  • woman not taking precaution to prevent pregnancy.
  • The non-inclusion specific criteria were the following ones:
  • application of care products to the face within 48 hours preceding the inclusion visit,
  • application of make-up products to the face the day of the inclusion visit,
  • face wash with any other means than clear water (no soap or cleanser) on the day of the inclusion visit,
  • application of self-tanning products to the face within 4 weeks preceding the inclusion visit,
  • Oral intake of food supplement within 1 month preceding the inclusion visit,
  • cutaneous marks on the face which could interfere with the skin's clinical signs assessment (pigmentation issues, scar tissues, over-developed hairiness, too many ephelides and naevi, sunburns...),
  • solar exposition (natural sun or UVA or heliotherapy treatment) within 4 weeks preceding the inclusion visit and expectation of solar exposition (natural or UVA) during the study,
  • Vitamin A acid treatment or its derivatives within 3 months preceding the pre-inclusion visit,
  • Retinoid based oral treatment within 6 months before the pre-inclusion visit, or local treatment within 2 months prior to this visit,
  • Carotene based treatment within 4 weeks preceding the inclusion visit,
  • expectation or having undergone aesthetic or dermatological surgery on the face.

研究者

发起方
Wuhan CASOV Green Biotech Co., Ltd
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验